Total Liabilities Summary of Grifols, S.A.

Grifols, S.A.'s latest annual total liabilities in 2023 was 13.46 Billion EUR , up 3.0% from previous year.
Grifols, S.A.'s latest quarterly total liabilities in 2024 Q1 was 13.83 Billion EUR , up 2.69% from previous quarter.
Grifols, S.A. reported annual total liabilities of 13.07 Billion EUR in 2022, up 17.95% from previous year.
Grifols, S.A. reported annual total liabilities of 11.08 Billion EUR in 2021, up 29.6% from previous year.
Grifols, S.A. reported quarterly total liabilities of 13.98 Billion EUR for 2024 Q2, up 1.19% from previous quarter.
Grifols, S.A. reported quarterly total liabilities of 13.46 Billion EUR for 2023 Q4, down -0.2% from previous quarter.

Annual Total Liabilities Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Total Liabilities of Grifols, S.A. (2023 - 2005)

Year	Total Liabilities	Total Liabilities Growth
2023	13.46 Billion EUR	3.0%
2022	13.07 Billion EUR	17.95%
2021	11.08 Billion EUR	29.6%
2020	8.55 Billion EUR	-1.63%
2019	8.69 Billion EUR	11.78%
2018	7.78 Billion EUR	6.78%
2017	7.28 Billion EUR	13.82%
2016	6.4 Billion EUR	1.61%
2015	6.3 Billion EUR	8.87%
2014	5.78 Billion EUR	54.98%
2013	3.73 Billion EUR	-0.34%
2012	3.74 Billion EUR	-9.56%
2011	4.14 Billion EUR	250.61%
2010	1.18 Billion EUR	9.54%
2009	1.07 Billion EUR	54.32%
2008	698.96 Million EUR	25.85%
2007	555.4 Million EUR	1.85%
2006	545.32 Million EUR	-28.78%
2005	765.73 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	13.83 Billion EUR	2.69%
2024 Q2	13.98 Billion EUR	1.19%
2023 Q4	13.46 Billion EUR	-0.2%
2023 Q3	13.49 Billion EUR	2.17%
2023 Q1	13.17 Billion USD	0.76%
2023 Q2	13.2 Billion EUR	0.25%
2023 FY	13.46 Billion EUR	3.0%
2022 Q4	13.07 Billion USD	0.0%
2022 FY	13.07 Billion EUR	17.95%
2022 Q2	12.61 Billion EUR	0.0%
2022 Q3	13.07 Billion EUR	3.62%
2022 Q1	- EUR	-100.0%
2021 Q1	8.94 Billion EUR	4.51%
2021 Q2	9.27 Billion EUR	3.75%
2021 Q3	11.91 Billion EUR	28.47%
2021 FY	11.08 Billion EUR	29.6%
2021 Q4	11.91 Billion USD	0.0%
2020 FY	8.55 Billion EUR	-1.63%
2020 Q4	8.55 Billion EUR	0.18%
2020 Q3	8.53 Billion EUR	-0.21%
2020 Q2	8.55 Billion EUR	-1.53%
2020 Q1	8.68 Billion EUR	-0.08%
2019 Q4	8.69 Billion EUR	-0.55%
2019 FY	8.69 Billion EUR	11.78%
2019 Q1	8.51 Billion EUR	9.38%
2019 Q2	8.43 Billion EUR	-0.85%
2019 Q3	8.74 Billion EUR	3.64%
2018 Q1	7.16 Billion EUR	-1.66%
2018 FY	7.78 Billion EUR	6.78%
2018 Q4	7.78 Billion EUR	1.94%
2018 Q3	7.63 Billion EUR	2.28%
2018 Q2	7.46 Billion EUR	4.14%
2017 Q4	7.28 Billion EUR	-1.83%
2017 Q2	7.53 Billion EUR	-4.55%
2017 FY	7.28 Billion EUR	13.82%
2017 Q1	7.89 Billion EUR	23.27%
2017 Q3	7.42 Billion EUR	-1.46%
2016 Q4	6.4 Billion EUR	6.07%
2016 Q2	6.12 Billion EUR	3.13%
2016 FY	6.4 Billion EUR	1.61%
2016 Q1	5.94 Billion EUR	-5.69%
2016 Q3	6.03 Billion EUR	-1.5%
2015 FY	6.3 Billion EUR	8.87%
2015 Q4	6.3 Billion EUR	5.44%
2015 Q3	5.97 Billion EUR	-0.76%
2015 Q2	6.02 Billion EUR	-3.5%
2015 Q1	6.23 Billion EUR	7.83%
2014 Q3	5.56 Billion EUR	10.41%
2014 Q2	5.03 Billion EUR	1.42%
2014 FY	5.78 Billion EUR	54.98%
2014 Q1	4.96 Billion EUR	33.05%
2014 Q4	5.78 Billion EUR	4.02%
2013 Q1	3.82 Billion EUR	2.12%
2013 Q2	3.9 Billion EUR	1.97%
2013 FY	3.73 Billion EUR	-0.34%
2013 Q3	3.74 Billion EUR	-4.09%
2013 Q4	3.73 Billion EUR	-0.22%
2012 Q1	3.85 Billion EUR	-6.87%
2012 Q4	3.74 Billion EUR	-5.94%
2012 Q3	3.98 Billion EUR	-2.24%
2012 FY	3.74 Billion EUR	-9.56%
2012 Q2	4.07 Billion EUR	5.61%
2011 Q4	4.14 Billion EUR	6.55%
2011 Q2	3.83 Billion EUR	0.0%
2011 FY	4.14 Billion EUR	250.61%
2011 Q3	3.88 Billion EUR	1.5%
2010 Q4	1.18 Billion EUR	0.0%
2010 FY	1.18 Billion EUR	9.54%
2009 FY	1.07 Billion EUR	54.32%
2008 FY	698.96 Million EUR	25.85%
2007 FY	555.4 Million EUR	1.85%
2006 FY	545.32 Million EUR	-28.78%
2005 FY	765.73 Million EUR	0.0%

Peer Total Liabilities Comparison of Grifols, S.A.

Name	Total Liabilities	Total Liabilities Difference
AstraZeneca PLC	61.86 Billion USD	78.23%
Bristol-Myers Squibb Company PFD CONV 2	65.67 Billion USD	79.492%
CSPC Pharmaceutical Group Limited	1.53 Billion USD	-774.676%
Clarus Therapeutics Holdings, Inc.	67.62 Million USD	-19815.682%
Novartis AG	53.19 Billion USD	74.681%
PT Kalbe Farma Tbk.	255.94 Million USD	-5162.308%

Global Stocks Search

Grifols, S.A. (GIKLY)

Total Liabilities Summary of Grifols, S.A.

Annual Total Liabilities Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Total Liabilities of Grifols, S.A. (2023 - 2005)

Peer Total Liabilities Comparison of Grifols, S.A.